Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 19 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2021 Filed Oct 1, 2021 23:27 UTC |
Anderson RaymondDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 751 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-010717 · section16.xml · derivative · entry 2 Anderson Raymond · CIK 0001362489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 751 Underlying: Common Stock · 751 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F2 · derivative.exercise_date: On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F2 · derivative.expiration_date: On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 23:27 UTC |
Anderson RaymondDirector
|
Exercise / conversionCommon Stock | 751 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-21-010717 · section16.xml · nonDerivative · entry 1 Anderson Raymond · CIK 0001362489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 23:31 UTC |
Mazar Andrew PaulDirector · Chief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-010720 · section16.xml · derivative · entry 5 Mazar Andrew Paul · CIK 0001727393 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,879 Underlying: Common Stock · 1,606 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F4 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 25,697 restricted stock units, vesting 6/48ths (3,212 shares) on June 30, 2021, and 3/48ths (1,606 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 25,697 restricted stock units, vesting 6/48ths (3,212 shares) on June 30, 2021, and 3/48ths (1,606 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 23:31 UTC |
Mazar Andrew PaulDirector · Chief Scientific Officer
|
Tax withholdingCommon Stock | 471 | $4.87 | $2,293.77 |
DisclosureSEC source: 0001654954-21-010720 · section16.xml · nonDerivative · entry 2 Mazar Andrew Paul · CIK 0001727393 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,673.8 Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 23:31 UTC |
Mazar Andrew PaulDirector · Chief Scientific Officer
|
Exercise / conversionCommon Stock | 1,606 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-21-010720 · section16.xml · nonDerivative · entry 1 Mazar Andrew Paul · CIK 0001727393 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,144.8 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 23:24 UTC |
Robinson ChandlerDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-010715 · section16.xml · derivative · entry 5 Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,236 Underlying: Common Stock · 3,941 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F4 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 63,060 restricted stock units, vesting 6/48ths (7,883 shares) on June 30, 2021, and 3/48ths (3,941 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 63,060 restricted stock units, vesting 6/48ths (7,883 shares) on June 30, 2021, and 3/48ths (3,941 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 23:24 UTC |
Robinson ChandlerDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 1,155 | $4.87 | $5,624.85 |
DisclosureSEC source: 0001654954-21-010715 · section16.xml · nonDerivative · entry 2 Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,758.8 Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 23:24 UTC |
Robinson ChandlerDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 3,941 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-21-010715 · section16.xml · nonDerivative · entry 1 Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,913.8 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| July 12, 2021 Filed Jul 13, 2021 16:35 UTC |
Filho Jose Octavio Pinto CostaChief Medical Officer
|
GrantStock Options · Derivative | 91,500 | $0.00 Strike: $5.59 | $0.00 |
DisclosureSEC source: 0001654954-21-007859 · section16.xml · derivative · entry 1 Filho Jose Octavio Pinto Costa · CIK 0001863625 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,500 Underlying: Common Stock · 91,500 shares Expires 2031-07-11 F1 · derivative.exercise_date: Options vest 6/48ths on January 12, 2022 and 1/48th per month thereafter. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 17:18 UTC |
Brown Michael JDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 752 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-007603 · section16.xml · derivative · entry 4 Brown Michael J · CIK 0001035909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,502 Underlying: Common Stock · 752 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F4 · derivative.exercise_date: On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.expiration_date: On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 17:18 UTC |
Brown Michael JDirector
|
Exercise / conversionCommon Stock | 752 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-21-007603 · section16.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 21:07 UTC |
Cittadine AndrewChief Operating Officer
|
GrantStock Options · Derivative | 30,000 | $0.00 Strike: $5.89 | $0.00 |
DisclosureSEC source: 0001654954-21-007591 · section16.xml · derivative · entry 1 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-05-31 F1 · derivative.exercise_date: Options vest 6/48ths on November 30, 2021 and 1/48th monthly on the last day of each month thereafter. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 17:18 UTC |
STARR CHRISTOPHER MDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 752 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-007605 · section16.xml · derivative · entry 3 STARR CHRISTOPHER M · CIK 0001235470 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,502 Underlying: Common Stock · 752 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F3 · derivative.exercise_date: On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F3 · derivative.expiration_date: On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 17:18 UTC |
STARR CHRISTOPHER MDirector
|
Exercise / conversionCommon Stock | 752 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-21-007605 · section16.xml · nonDerivative · entry 1 STARR CHRISTOPHER M · CIK 0001235470 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 21:16 UTC |
KLAUSNER ARTHUR JDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 752 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-007599 · section16.xml · derivative · entry 3 KLAUSNER ARTHUR J · CIK 0001207790 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,502 Underlying: Common Stock · 752 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units F3 · derivative.exercise_date: On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F3 · derivative.expiration_date: On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 21:16 UTC |
KLAUSNER ARTHUR JDirector
|
Exercise / conversionCommon Stock | 752 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-21-007599 · section16.xml · nonDerivative · entry 1 KLAUSNER ARTHUR J · CIK 0001207790 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 21:13 UTC |
Tsuchimoto Kim RChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,442 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-007597 · section16.xml · derivative · entry 3 Tsuchimoto Kim R · CIK 0001333516 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,094 Underlying: Common Stock · 2,442 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F2 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F2 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 21:13 UTC |
Tsuchimoto Kim RChief Financial Officer
|
Tax withholdingCommon Stock | 823 | $5.89 | $4,847.47 |
DisclosureSEC source: 0001654954-21-007597 · section16.xml · nonDerivative · entry 2 Tsuchimoto Kim R · CIK 0001333516 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,671 Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 21:13 UTC |
Tsuchimoto Kim RChief Financial Officer
|
Exercise / conversionCommon Stock | 2,442 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-21-007597 · section16.xml · nonDerivative · entry 1 Tsuchimoto Kim R · CIK 0001333516 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 21:18 UTC |
Anderson RaymondDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 752 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-007604 · section16.xml · derivative · entry 2 Anderson Raymond · CIK 0001362489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,502 Underlying: Common Stock · 752 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F2 · derivative.exercise_date: On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F2 · derivative.expiration_date: On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 21:18 UTC |
Anderson RaymondDirector
|
Exercise / conversionCommon Stock | 752 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-21-007604 · section16.xml · nonDerivative · entry 1 Anderson Raymond · CIK 0001362489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 21:11 UTC |
Mazar Andrew PaulDirector · Chief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-007595 · section16.xml · derivative · entry 5 Mazar Andrew Paul · CIK 0001727393 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,485 Underlying: Common Stock · 3,212 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F4 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 25,697 restricted stock units, vesting 6/48ths (3,212 shares) on June 30, 2021, and 3/48ths (1,606 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 25,697 restricted stock units, vesting 6/48ths (3,212 shares) on June 30, 2021, and 3/48ths (1,606 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 21:11 UTC |
Mazar Andrew PaulDirector · Chief Scientific Officer
|
Tax withholdingCommon Stock | 942 | $5.89 | $5,548.38 |
DisclosureSEC source: 0001654954-21-007595 · section16.xml · nonDerivative · entry 2 Mazar Andrew Paul · CIK 0001727393 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,538.8 Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 21:11 UTC |
Mazar Andrew PaulDirector · Chief Scientific Officer
|
Exercise / conversionCommon Stock | 3,212 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-21-007595 · section16.xml · nonDerivative · entry 1 Mazar Andrew Paul · CIK 0001727393 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,480.8 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 21:10 UTC |
Robinson ChandlerDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,883 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-007593 · section16.xml · derivative · entry 5 Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,177 Underlying: Common Stock · 7,883 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F4 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 63,060 restricted stock units, vesting 6/48ths (7,883 shares) on June 30, 2021, and 3/48ths (3,941 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 63,060 restricted stock units, vesting 6/48ths (7,883 shares) on June 30, 2021, and 3/48ths (3,941 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 21:10 UTC |
Robinson ChandlerDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 2,310 | $5.89 | $13,605.90 |
DisclosureSEC source: 0001654954-21-007593 · section16.xml · nonDerivative · entry 2 Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,972.8 Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 21:10 UTC |
Robinson ChandlerDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 7,883 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-21-007593 · section16.xml · nonDerivative · entry 1 Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,282.8 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:11 UTC |
Cittadine AndrewChief Operating Officer
|
GrantStock Options · Derivative | 70,000 | $0.00 Strike: $5.76 | $0.00 |
DisclosureSEC source: 0001654954-21-006531 · section16.xml · derivative · entry 1 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2031-05-31 F1 · derivative.exercise_date: Options vest 6/48ths on November 30, 2021 and 1/48th monthly on the last day of each month thereafter. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 19:42 UTC |
Brown Michael JDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 751 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-003791 · section16.xml · derivative · entry 4 Brown Michael J · CIK 0001035909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,254 Underlying: Common Stock · 751 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F4 · derivative.exercise_date: On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.expiration_date: On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 19:42 UTC |
Brown Michael JDirector
|
Exercise / conversionCommon Stock | 751 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-21-003791 · section16.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 19:49 UTC |
STARR CHRISTOPHER MDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 751 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-003796 · section16.xml · derivative · entry 3 STARR CHRISTOPHER M · CIK 0001235470 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,254 Underlying: Common Stock · 751 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F3 · derivative.exercise_date: On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F3 · derivative.expiration_date: On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 19:49 UTC |
STARR CHRISTOPHER MDirector
|
Exercise / conversionCommon Stock | 751 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-21-003796 · section16.xml · nonDerivative · entry 1 STARR CHRISTOPHER M · CIK 0001235470 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 23:45 UTC |
KLAUSNER ARTHUR JDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 751 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-003793 · section16.xml · derivative · entry 3 KLAUSNER ARTHUR J · CIK 0001207790 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,254 Underlying: Common Stock · 751 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F3 · derivative.exercise_date: On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F3 · derivative.expiration_date: On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 23:45 UTC |
KLAUSNER ARTHUR JDirector
|
Exercise / conversionCommon Stock | 751 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-21-003793 · section16.xml · nonDerivative · entry 1 KLAUSNER ARTHUR J · CIK 0001207790 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 23:41 UTC |
Anderson RaymondDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 751 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-003789 · section16.xml · derivative · entry 2 Anderson Raymond · CIK 0001362489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,254 Underlying: Common Stock · 751 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F2 · derivative.exercise_date: On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F2 · derivative.expiration_date: On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 23:41 UTC |
Anderson RaymondDirector
|
Exercise / conversionCommon Stock | 751 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-21-003789 · section16.xml · nonDerivative · entry 1 Anderson Raymond · CIK 0001362489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 19:35 UTC |
Tactic Pharma LLC10% owner
Mazar Andrew PaulDirector · Chief Scientific Officer
Robinson ChandlerDirector · Chief Executive Officer
O'Halloran Thomas V.10% owner
Brown Michael JDirector
|
SaleCommon stock | 11,929 | $16.90 | $201,600.10 |
DisclosureSEC source: 0001654954-21-001750 · section16.xml · nonDerivative · entry 5 Tactic Pharma LLC · CIK 0001727357 · 10% owner Mazar Andrew Paul · CIK 0001727393 · Director · Chief Scientific Officer Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer O'Halloran Thomas V. · CIK 0001727481 · 10% owner Brown Michael J · CIK 0001035909 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,667 F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 24, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.77 to $17.01, inclusive. F2 · ownership.direct: This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company ("Tactic"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the "Reporting Persons"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 19:35 UTC |
Tactic Pharma LLC10% owner
Mazar Andrew PaulDirector · Chief Scientific Officer
Robinson ChandlerDirector · Chief Executive Officer
O'Halloran Thomas V.10% owner
Brown Michael JDirector
|
SaleCommon stock | 16,384 | $16.44 | $269,352.96 |
DisclosureSEC source: 0001654954-21-001750 · section16.xml · nonDerivative · entry 4 Tactic Pharma LLC · CIK 0001727357 · 10% owner Mazar Andrew Paul · CIK 0001727393 · Director · Chief Scientific Officer Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer O'Halloran Thomas V. · CIK 0001727481 · 10% owner Brown Michael J · CIK 0001035909 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,596 F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 24, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.77 to $16.76, inclusive. F2 · ownership.direct: This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company ("Tactic"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the "Reporting Persons"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 19:35 UTC |
Tactic Pharma LLC10% owner
Mazar Andrew PaulDirector · Chief Scientific Officer
Robinson ChandlerDirector · Chief Executive Officer
O'Halloran Thomas V.10% owner
Brown Michael JDirector
|
SaleCommon stock | 29,996 | $15.12 | $453,539.52 |
DisclosureSEC source: 0001654954-21-001750 · section16.xml · nonDerivative · entry 3 Tactic Pharma LLC · CIK 0001727357 · 10% owner Mazar Andrew Paul · CIK 0001727393 · Director · Chief Scientific Officer Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer O'Halloran Thomas V. · CIK 0001727481 · 10% owner Brown Michael J · CIK 0001035909 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,980 F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 24, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.76 to $15.75, inclusive. F2 · ownership.direct: This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company ("Tactic"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the "Reporting Persons"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 19:35 UTC |
Tactic Pharma LLC10% owner
Mazar Andrew PaulDirector · Chief Scientific Officer
Robinson ChandlerDirector · Chief Executive Officer
O'Halloran Thomas V.10% owner
Brown Michael JDirector
|
SaleCommon stock | 24,224 | $14.09 | $341,316.16 |
DisclosureSEC source: 0001654954-21-001750 · section16.xml · nonDerivative · entry 2 Tactic Pharma LLC · CIK 0001727357 · 10% owner Mazar Andrew Paul · CIK 0001727393 · Director · Chief Scientific Officer Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer O'Halloran Thomas V. · CIK 0001727481 · 10% owner Brown Michael J · CIK 0001035909 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,976 F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 24, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.66 to $14.54, inclusive. F2 · ownership.direct: This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company ("Tactic"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the "Reporting Persons"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 19:35 UTC |
Tactic Pharma LLC10% owner
Mazar Andrew PaulDirector · Chief Scientific Officer
Robinson ChandlerDirector · Chief Executive Officer
O'Halloran Thomas V.10% owner
Brown Michael JDirector
|
SaleCommon stock | 42,467 | $13.30 | $564,811.10 |
DisclosureSEC source: 0001654954-21-001750 · section16.xml · nonDerivative · entry 1 Tactic Pharma LLC · CIK 0001727357 · 10% owner Mazar Andrew Paul · CIK 0001727393 · Director · Chief Scientific Officer Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer O'Halloran Thomas V. · CIK 0001727481 · 10% owner Brown Michael J · CIK 0001035909 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,200 F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 24, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.66 to $13.65, inclusive. The reporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4. F2 · ownership.direct: This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company ("Tactic"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the "Reporting Persons"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 18:56 UTC |
Brown Michael JDirector
|
GrantRestricted Stock Units · Derivative | 3,005 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-000919 · section16.xml · derivative · entry 2 Brown Michael J · CIK 0001035909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,005 Underlying: Common Stock · 3,005 shares Expires not disclosed F2 · derivative.exercise_date: RSUs vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021. F2 · derivative.expiration_date: RSUs vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 18:56 UTC |
Brown Michael JDirector
|
GrantStock Options · Derivative | 4,443 | $0.00 Strike: $6.81 | $0.00 |
DisclosureSEC source: 0001654954-21-000919 · section16.xml · derivative · entry 1 Brown Michael J · CIK 0001035909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,443 Underlying: Common Stock · 4,443 shares Expires 2031-01-25 F1 · derivative.exercise_date: Options vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 18:54 UTC |
STARR CHRISTOPHER MDirector
|
GrantRestricted Stock Units · Derivative | 3,005 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-000917 · section16.xml · derivative · entry 2 STARR CHRISTOPHER M · CIK 0001235470 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,005 Underlying: Common Stock · 3,005 shares Expires not disclosed F2 · derivative.exercise_date: RSUs vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021. F2 · derivative.expiration_date: RSUs vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 18:54 UTC |
STARR CHRISTOPHER MDirector
|
GrantStock Options · Derivative | 4,443 | $0.00 Strike: $6.81 | $0.00 |
DisclosureSEC source: 0001654954-21-000917 · section16.xml · derivative · entry 1 STARR CHRISTOPHER M · CIK 0001235470 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,443 Underlying: Common Stock · 4,443 shares Expires 2031-01-25 F1 · derivative.exercise_date: Options vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021. Read SEC document |
| January 26, 2021 Filed Jan 29, 2021 00:02 UTC |
KLAUSNER ARTHUR JDirector
|
GrantRestricted Stock Units · Derivative | 3,005 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-000923 · section16.xml · derivative · entry 2 KLAUSNER ARTHUR J · CIK 0001207790 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,005 Underlying: Common Stock · 3,005 shares Expires not disclosed F2 · derivative.exercise_date: RSUs vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021. F2 · derivative.expiration_date: RSUs vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021. Read SEC document |
| January 26, 2021 Filed Jan 29, 2021 00:02 UTC |
KLAUSNER ARTHUR JDirector
|
GrantStock Options · Derivative | 4,443 | $0.00 Strike: $6.81 | $0.00 |
DisclosureSEC source: 0001654954-21-000923 · section16.xml · derivative · entry 1 KLAUSNER ARTHUR J · CIK 0001207790 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,443 Underlying: Common Stock · 4,443 shares Expires 2031-01-25 F1 · derivative.exercise_date: Options vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 23:53 UTC |
Tsuchimoto Kim RChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 19,536 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-000915 · section16.xml · derivative · entry 2 Tsuchimoto Kim R · CIK 0001333516 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,228 Underlying: Common Stock · 19,536 shares Expires not disclosed F2 · derivative.exercise_date: RSUs vest 6/48ths on June 30, 2021 and 3/48ths each quarter-end thereafter (September 30, 2021, December 31, 2021, March 31, 2022, June 30, 2022, September 30, 2022, December 31, 2022, March 31, 2023, June 30, 2023, September 30, 2023, December 31, 2023, March 31, 2024, June 30, 2024, September 30, 2024, December 31, 2024) F2 · derivative.expiration_date: RSUs vest 6/48ths on June 30, 2021 and 3/48ths each quarter-end thereafter (September 30, 2021, December 31, 2021, March 31, 2022, June 30, 2022, September 30, 2022, December 31, 2022, March 31, 2023, June 30, 2023, September 30, 2023, December 31, 2023, March 31, 2024, June 30, 2024, September 30, 2024, December 31, 2024) Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 23:53 UTC |
Tsuchimoto Kim RChief Financial Officer
|
GrantStock Options · Derivative | 27,427 | $0.00 Strike: $6.81 | $0.00 |
DisclosureSEC source: 0001654954-21-000915 · section16.xml · derivative · entry 1 Tsuchimoto Kim R · CIK 0001333516 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,427 Underlying: Common Stock · 27,427 shares Expires 2031-01-25 F1 · derivative.exercise_date: Options vest 6/48ths on June 30, 2021 and 1/48th monthly on the last day of each month thereafter. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 23:57 UTC |
Anderson RaymondDirector
|
GrantRestricted Stock Units · Derivative | 3,005 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-000921 · section16.xml · derivative · entry 2 Anderson Raymond · CIK 0001362489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,005 Underlying: Common Stock · 3,005 shares Expires not disclosed F2 · derivative.exercise_date: RSUs vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021. F2 · derivative.expiration_date: RSUs vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.